1-147181057-G-A

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001348451.2(CHD1L):​c.-90+6472G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.373 in 152,052 control chromosomes in the GnomAD database, including 10,989 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.37 ( 10989 hom., cov: 32)

Consequence

CHD1L
NM_001348451.2 intron

Scores

1

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.38
Variant links:
Genes affected
CHD1L (HGNC:1916): (chromodomain helicase DNA binding protein 1 like) This gene encodes a DNA helicase protein involved in DNA repair. The protein converts ATP to add poly(ADP-ribose) as it regulates chromatin relaxation following DNA damage. Overexpression of this gene has been linked to several types of cancers. [provided by RefSeq, Feb 2017]
FMO5 (HGNC:3773): (flavin containing dimethylaniline monoxygenase 5) Metabolic N-oxidation of the diet-derived amino-trimethylamine (TMA) is mediated by flavin-containing monooxygenase and is subject to an inherited FMO3 polymorphism in man resulting in a small subpopulation with reduced TMA N-oxidation capacity resulting in fish odor syndrome Trimethylaminuria. Three forms of the enzyme, FMO1 found in fetal liver, FMO2 found in adult liver, and FMO3 are encoded by genes clustered in the 1q23-q25 region. Flavin-containing monooxygenases are NADPH-dependent flavoenzymes that catalyzes the oxidation of soft nucleophilic heteroatom centers in drugs, pesticides, and xenobiotics. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.49 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CHD1LNM_001348451.2 linkuse as main transcriptc.-90+6472G>A intron_variant NP_001335380.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FMO5ENST00000527849.5 linkuse as main transcriptn.*259-4667C>T intron_variant 5 ENSP00000433742.1 E9PJF3
ENSG00000237188ENST00000606757.1 linkuse as main transcriptn.258+6472G>A intron_variant 3
ENSG00000237188ENST00000606856.1 linkuse as main transcriptn.536+6472G>A intron_variant 5

Frequencies

GnomAD3 genomes
AF:
0.373
AC:
56638
AN:
151930
Hom.:
10972
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.496
Gnomad AMI
AF:
0.294
Gnomad AMR
AF:
0.340
Gnomad ASJ
AF:
0.298
Gnomad EAS
AF:
0.297
Gnomad SAS
AF:
0.401
Gnomad FIN
AF:
0.323
Gnomad MID
AF:
0.334
Gnomad NFE
AF:
0.322
Gnomad OTH
AF:
0.354
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.373
AC:
56691
AN:
152052
Hom.:
10989
Cov.:
32
AF XY:
0.372
AC XY:
27666
AN XY:
74306
show subpopulations
Gnomad4 AFR
AF:
0.496
Gnomad4 AMR
AF:
0.339
Gnomad4 ASJ
AF:
0.298
Gnomad4 EAS
AF:
0.297
Gnomad4 SAS
AF:
0.401
Gnomad4 FIN
AF:
0.323
Gnomad4 NFE
AF:
0.322
Gnomad4 OTH
AF:
0.353
Alfa
AF:
0.334
Hom.:
9179
Bravo
AF:
0.374

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
5.8

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2077749; hg19: chr1-146652637; API